AndreaBozzo/ceres-open-data-index huggingface dataset:
Patent AT-E400890-T1: [Translated] INTRODUCING MERCURY INTO A DISCHARGE LAMP

The invention relates to methods of manufacturing gas-discharge electron lamps, and neon tubes in particular. According to the invention, it is proposed, prior to carrying out vacuum treatment of the internal space of an electron lamp (1), to mount at least one of said glass capsules (2) in exhaust tube (5), in close proximity to an exposed electrode in such manner that the opening provided in metal container (4) is facing the working area of the lamp (1). Upon carrying out vacuum treatment and filling the internal space with an inert gas, the portion of exhaust tube (5) that contains capsule (2) disposed within metal container (4) is separated from evacuation unit (10), and this area is subjected to the local effect of a high-power electromagnetic radiation, thereby causing substantially instantaneous heating of metal container (4), which results in a rupture of glass capsule (2) and intense evaporation of the liquid mercury, thereby resulting in a directional flow of pure mercury vapor, which flow rapidly fills up said internal space of the tube through the opening provided in metal container (4). Such method permits to provide environmentally safe production and to eliminate contamination of mercury inside the working space of a lamp, which in turn allows carrying out precise dosing and introduction of calculated minimal amounts of mercury. In addition, the inventive method does not require application of special electrodes and might be used in any mass manufacture of commercial products, and neon tubes in particular.
Compound 529223: Hexanamine, 1,5-dimethyl, mono-DMTBS

Chemical compound data from PubChem database. IUPAC Name: N-[tert-butyl(dimethyl)silyl]-N,5-dimethylhexan-1-amine. Molecular Formula: C14H33NSi. Molecular Weight: 243.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, (age <5 years), Non-b serotype to Unknown serotype

NNDSS - TABLE 1N. Haemophilus influenzae, invasive disease, (age <5 years), Non-b serotype to Unknown serotype - 2019. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents. 

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published — CDC does not have data because of changes in how conditions are categorized.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2018 and 2019 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the US, a US territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-US Residents' category. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf. 
† Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
The human olfactory receptor repertoire

Background
          The mammalian olfactory apparatus is able to recognize and distinguish thousands of structurally diverse volatile chemicals. This chemosensory function is mediated by a very large family of seven-transmembrane olfactory (odorant) receptors encoded by approximately 1,000 genes, the majority of which are believed to be pseudogenes in humans.
        
        
          Results
          The strategy of our sequence database mining for full-length, functional candidate odorant receptor genes was based on the high overall sequence similarity and presence of a number of conserved sequence motifs in all known mammalian odorant receptors as well as the absence of introns in their coding sequences. We report here the identification and physical cloning of 347 putative human full-length odorant receptor genes. Comparative sequence analysis of the predicted gene products allowed us to identify and define a number of consensus sequence motifs and structural features of this vast family of receptors. A new nomenclature for human odorant receptors based on their chromosomal localization and phylogenetic analysis is proposed. We believe that these sequences represent the essentially complete repertoire of functional human odorant receptors.
        
        
          Conclusions
          The identification and cloning of all functional human odorant receptor genes is an important initial step in understanding receptor-ligand specificity and combinatorial encoding of odorant stimuli in human olfaction.
5-Fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report

Background
          Severe cardiotoxicity is a documented, but very unusual side-effect of intravenous 5-fluorouracil therapy. The mechanism producing cardiotoxicity is poorly understood.
        
        
          Case presentation
          A case of 5-fluorouracil-induced cardiotoxicity, possibly due to coronary artery spasm, and mimicking acute anterolateral myocardial infarction is presented and discussed. Electrocardiographs highlighting the severity of the presentation are included in the report along with coronary angiograms demonstrating the absence of significant coronary atherosclerosis.
        
        
          Conclusion
          Severe 5-fluorouracil-induced cardiotoxicity is rare, but can be severe and may mimic acute myocardial infarction, leading to diagnostic and therapeutic dilemmas. Readministration of 5-fluorouracil is not advised following an episode of cardiotoxicity.
Compound 527548: 1,3-Cyclohexadiene, 1-bromo

Chemical compound data from PubChem database. IUPAC Name: 1-bromocyclohexa-1,3-diene. Molecular Formula: C6H7Br. Molecular Weight: 159.02. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Statewide SPM Poverty Rates Over Time - Children Under 18 year - 1yr ACS - Supplemental Poverty Measure

The Supplemental Poverty Measure (SPM) dataset comes from the U.S. Census Bureau and is considered to be equal to or even better than the Official Poverty Measure, as a KPI. This dataset contains the SPM statewide over time and includes the number and percentage of people below poverty for select demographics.

Note: The Census Bureau did not release its standard 2020 ACS 1-year estimates because of the impacts of the COVID-19 pandemic. Instead, the Census Bureau released experimental estimates from the 1-year data. They are posted on the 2020 ACS 1-Year Experimental Data Release page. They will not be released on data.census.gov and are not included in this dataset.

Data are based on a sample and are subject to sampling variability. A margin of error is a measure of an estimate’s variability. The larger the margin of error in relation to the size of the estimate, the less reliable the estimate. This number when added to or subtracted from the estimate forms the 90 percent confidence interval. Margin of Error rates for each field in the dataset are attached in the metadata.
Tribal Initiatives

P.L. 102-477 (referred to as “477”) is the Indian Employment, Training and Related Services Demonstration Act. 477 (as amended) allows federally recognized tribes and Alaska Native entities to integrate federal grant programs for employment, training, and related services they provide to their communities into a single program plan, budget, and reporting system to address tribal priorities.

Learn about 477

The Administration for Children and Families’ (ACF) developed a framework  (PDF)for addressing missing and murdered indigenous people (MMIP) to help communities address the consequences of this tragic problem.

Take a look at the Tribal Early Childhood Working Group Summary Report and Blueprint (PDF) for Action that charts out next steps to improve coordination and collaboration for programs serving Native American young children and their families.

Tribal Early Childhood Working Group
	(PDF)

Hunger does not discriminate, and in all regions served by ACF, Tribal communities experience high rates of food insecurity and a lack of access to inexpensive, healthy foods. Failure to secure an affordable and nutritious food source can have troubling consequences to the health, social, economic, and educational well-being of Native community members, children, and families.

Ending Hunger and Improving Physical Wellness in Native Communities

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 530739: 3-Fluorobenzoic acid, but-3-yn-2-yl ester

Chemical compound data from PubChem database. IUPAC Name: but-3-yn-2-yl 3-fluorobenzoate. Molecular Formula: C11H9FO2. Molecular Weight: 192.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Detroit: Drug-Related Emergency Department Visits, 2004-2011 - Accidental Ingestions

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving accidental ingestions in the Detroit metropolitan area. This analytic category includes ED visits in which an individual accidentally or unknowingly used or was administered a prescription drug, over-the-counter medication, or dietary supplement. Drug-related accidental ingestion typically involves patients aged 5 and under.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 529311: Oxetane, 3-ethyl-3-(3-methylbutyl)

Chemical compound data from PubChem database. IUPAC Name: 3-ethyl-3-(3-methylbutyl)oxetane. Molecular Formula: C10H20O. Molecular Weight: 156.26. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401041-T1: [Translated] ADHESIVE-FREE DENTAL ARTICULATOR

The present invention provides a low-cost, durable dental articulator that does not require the use of toxic or messy glues. The articulator is composed of a pair of bands that encircle and are attached to the plaster upper and lower teeth bases of the model, a pair of spheres that mechanically attach to the bands at any of several positions corresponding to the rear of the mouth on the dental model, and a hinge assembly simulating movement of the jaw and made of two arcs attached to each other at their ends by a hinge mechanism and having clamps at their apexes for attaching to the spheres. The dental model can be adjusted to mimic the occlusion of the patient by adjusting the position at which the spheres are attached to the bands and the position of the spheres in the clamps.
Approved Animal Drug Products (Green Book)

On November 16, 1988, the President of the United States signed into law the Generic Animal Drug and Patent Restoration Act (GADPTRA). Among its major provisions, the Act extends eligibility for submission of Abbreviated New Animal Drug Applications (ANADAs) to all animal drug products approved for safety and effectiveness under the Federal Food, Drug, and Cosmetic Act. The Act also requires that each sponsor of an approved animal drug product submit to the FDA certain information regarding patents held for the animal drug or its method of use. The Act requires that this information, as well as a list of all animal drug products approved for safety and effectiveness, be made available to the public. This list must be updated monthly under the provisions of the Act. This publication, which is known as the �Green Book�, was first published in January of 1989. Updates have been added monthly since then. The list is published in its entirety each January.
Comparison of various characteristics of women who do and do not attend for breast cancer screening

Background
          Information regarding the characteristics and health of women who do and do not attend for breast cancer screening is limited and representative data are difficult to obtain.
        
        
          Methods
          Information on age, deprivation and prescriptions for various medications was obtained for all women at two UK general practices who were invited to breast cancer screening through the National Health Service Breast Screening Programme. The characteristics of women who attended and did not attend screening were compared.
        
        
          Results
          Of the 1064 women invited to screening from the two practices, 882 (83%) attended screening. Screening attenders were of a similar age to non-attenders but came from significantly less deprived areas (30% of attenders versus 50% of non-attenders came from the most deprived areas, P < 0.0001) and were more likely to have a current prescription for hormone replacement therapy (32% versus 19%, P < 0.0001). No significant differences in recent prescriptions of medication for hypertension, heart disease, hypercholesterolaemia, diabetes mellitus, asthma, thyroid disease or depression/anxiety were observed between attenders and non-attenders.
        
        
          Conclusion
          Women who attend the National Health Service Breast Screening Programme come from less deprived areas and are more likely to have a current prescription for hormone replacement therapy than non-attenders, but do not differ in terms of age or recent prescriptions for various other medications.
Compound 530393: 2,6,8-Decatrienamide, N-(2-phenylethyl)-, (2E,6Z,8E)-

Chemical compound data from PubChem database. IUPAC Name: N-(2-phenylethyl)deca-2,6,8-trienamide. Molecular Formula: C18H23NO. Molecular Weight: 269.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Responding to Child Maltreatment: A Children's Hospital Perspective

Experts in providing compassionate, personalized pediatric care, children’s hospitals are leaders in child abuse treatment and prevention in partnership with a variety of professionals and agencies. In 2005 NACHRI surveyed its members to assess a baseline of children's hospitals' responses to child abuse and neglect, with a second survey in 2008 to establish trend data. This webinar presents findings of the 2008 survey including the challenges of increasing caseload and financial sustainability.

Presenters: Nancy Hanson, Associate Director, Child Advocacy, and Karen Seaver Hill, director, Child Advocacy, National Association of Children's Hospitals and Related Institutions (NACHRI); Dr. Frank Putnam, Director, Advocacy Center at the Mayerson Center for Safe and Healthy Children, Cincinnati Children's Hospital Medical Center

View Webinar (WMV - 54 MB)

Metadata-only record linking to the original dataset. Open original dataset below.
Compound 529350: 3-(But-1-EN-1-YL)pyridine

Chemical compound data from PubChem database. IUPAC Name: 3-but-1-enylpyridine. Molecular Formula: C9H11N. Molecular Weight: 133.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529351: Pyridine, 4-(1-methylethenyl)

Chemical compound data from PubChem database. IUPAC Name: 4-prop-1-en-2-ylpyridine. Molecular Formula: C8H9N. Molecular Weight: 119.16. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage

Background:
          Cerebral vasospasm is a poor resulting outcome of a ruptured cerebral aneurysm; to clarify the mechanism of vasospasm it is important to improve this outcome. C-type natriuretic peptide (CNP) is present in the brain as a cerebral vasodilator; it is also an endothelium-derived relaxing factor produced via cGMP. We speculated that CNP might be an inhibitor of cerebral vasospasm after subarachnoid hemorrhage (SAH).
        
        
          Methods:
          To clarify the role of CNP in cerebral vasospasm after SAH, we conducted 1 week monitoring of CNP concentrations in the plasma and cerebrospinal fluid (CSF) of 26 patients who had undergone clipping within 24 hours of the occurrence of SAH, and divided them into group A (positive for angiographic spasm) and group B (negative for angiographic spasm). We also examined CNP concentrations in the CSF of patients who were receiving spinal anesthesia for small orthopedic operations, as reference patients.
        
        
          Results:
          The CNP concentration in the CSF on day 1 was higher than in the reference patients and decreased in both test groups, but we did not observe any significant difference between the groups. CNP concentrations in the plasma did not change in either group.
        
        
          Conclusions:
          CNP concentrations in the CSF were high in the acute phase after SAH, whereas plasma CNP concentrations remained constant. However, our findings did not support our hypothesis because we did not find any relationship between vasospasm and changes in CNP concentrations in the CSF.
Compound 528232: bis-[2-(Vinylthio)ethyl] ether

Chemical compound data from PubChem database. IUPAC Name: 1-ethenylsulfanyl-2-(2-ethenylsulfanylethoxy)ethane. Molecular Formula: C8H14OS2. Molecular Weight: 190.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Houston-Sugar Land-Baytown, TX

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Houston-Sugar Land-Baytown, TX metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Houston-Sugar Land-Baytown metro area, Texas, and the U.S. overall.
2013 CMHS Uniform Reporting System (URS) Tables for Delaware

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for Delaware for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 528628: Propanamide, N-butyl-2,2-dimethyl

Chemical compound data from PubChem database. IUPAC Name: N-butyl-2,2-dimethylpropanamide. Molecular Formula: C9H19NO. Molecular Weight: 157.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526691: 1,5-anhydro-2,3,4-tri-O-methyl-D-fucitol

Chemical compound data from PubChem database. IUPAC Name: 3,4,5-trimethoxy-2-methyloxane. Molecular Formula: C9H18O4. Molecular Weight: 190.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528882: Octopamine, N-acetyl-TFA

Chemical compound data from PubChem database. IUPAC Name: [4-[2-acetamido-1-(2,2,2-trifluoroacetyl)oxyethyl]phenyl] 2,2,2-trifluoroacetate. Molecular Formula: C14H11F6NO5. Molecular Weight: 387.23. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Inpatient Discharges by Patient County of Residence (SPARCS De-Identified): Beginning 2009

This dataset is a summary of hospital inpatient discharges from every hospital including Article 28 facilities; Ambulatory Surgery and Emergency Department visits, from the Statewide Planning and Research Cooperative System (SPARCS). The data is rolled up by patient county of residence. This dataset was modified in September 2013 to be in sync with the release of the Hospital Inpatient Discharges (SPARCS De-Identified) datasets. Please refer to the data dictionary for information on the current data available.

The SPARCS data has been divided into two distinct datasets: Hospital Discharges by Patient County of Residence and Hospital Discharges by Facility. This is to preserve the confidentiality of identifiable individual information.This dataset does not include facility names.